An ovarian cyst is a fluid-filled sac that develops on or within an ovary. Ovarian cysts are extremely common — most women develop at least one during their reproductive lifetime — and the overwhelming majority are benign and resolve spontaneously. However, accurate characterization with imaging is essential because specific cyst types carry different clinical implications, and a small subset requires intervention to exclude or treat malignancy.
The term "ovarian cyst" encompasses a spectrum of very different entities that require individualized evaluation. A simple functional cyst resolves within one to two menstrual cycles without any treatment. A hemorrhagic ovarian cyst contains blood and must be distinguished from an endometrioma — both appear similar on ultrasound but behave completely differently over time. A dermoid cyst (mature cystic teratoma) and a cystadenoma are benign neoplasms that typically require surgical removal. At the concerning end of the spectrum, complex cysts may represent ovarian cancer — the most important diagnosis to exclude. MRI is the definitive tool for making these distinctions when ultrasound findings are equivocal.
Causes
Normal ovulatory physiology.
The most common ovarian cysts — collectively termed functional cysts — arise directly from the normal menstrual cycle and are physiologic rather than pathologic. Follicular cysts develop when a dominant follicle (the fluid-filled sac containing a maturing egg) fails to rupture and release the egg at ovulation; it continues to accumulate follicular fluid and may reach 3–8 cm before eventually collapsing and resorbing. Corpus luteum cysts form after successful ovulation when the ruptured follicle seals, fills with fluid and blood rather than regressing normally, and persists as a cyst — this is the corpus luteum variant that most commonly becomes hemorrhagic. Both types are under hormonal control, are almost exclusively seen during the reproductive years, and resolve spontaneously within 1–2 menstrual cycles without intervention in the majority of cases.
Other contributing factors.
Non-functional ovarian cysts arise from different mechanisms. Endometriomas form when endometrial tissue implants on the ovary and bleeds cyclically with each menstrual cycle. Dermoid cysts arise from pluripotent germ cells and contain mature tissues from all three embryologic germ layers — skin, hair, fat, teeth, and sometimes neural or thyroid tissue. Cystadenomas are benign epithelial ovarian neoplasms that arise from the ovarian surface epithelium and can grow quite large. Paraovarian cysts arise from embryologic remnants adjacent to but separate from the ovary and are often mistaken for ovarian cysts on imaging. Risk factors for developing ovarian cysts vary by type: hormonal fluctuations and fertility medications increase functional cyst formation; endometriosis drives endometrioma development; and genetic factors influence neoplastic cyst risk.
Symptoms
Many ovarian cysts cause no symptoms and are discovered incidentally on imaging performed for an entirely unrelated reason — pelvic ultrasound ordered for urinary symptoms, or an abdominal CT scan performed for unrelated abdominal pain. When symptoms occur they typically include a dull ache or pressure in the lower abdomen or pelvis on the side of the affected ovary, bloating, pelvic fullness, pain with intercourse (deep dyspareunia) or with bowel movements. Larger cysts — particularly dermoids and cystadenomas that can reach 10–20 cm — may produce a visible or palpable lower abdominal mass, urinary frequency or urgency from bladder compression, and difficulty with defecation from rectal compression. Irregular menstrual cycles may occur when cysts disrupt normal ovarian hormone production. Sudden, severe, unilateral pelvic pain should raise immediate concern for cyst rupture — which releases fluid into the peritoneal cavity and causes peritoneal irritation — or for ovarian torsion, where the enlarged ovary twists on its vascular pedicle, cutting off blood supply to the ovary and requiring emergency surgical detorsion to prevent ovarian loss.
Diagnosis
Pelvic ultrasound — particularly transvaginal ultrasound — is the standard initial imaging test and reliably identifies the presence and basic morphology of most ovarian cysts. Simple cysts (thin-walled, anechoic, no internal echoes or solid components) carry essentially no malignant risk in premenopausal women and can be safely monitored with follow-up ultrasound. CA-125 serum tumor marker is measured when a morphologically complex or suspicious cyst is identified, particularly in postmenopausal women — though it lacks specificity and can be elevated by many benign conditions including endometriosis, fibroids, and pelvic infection.
An MRI of the pelvis is the most accurate characterization tool when ultrasound findings are equivocal, complex, or atypical. MRI's multiparametric capability — T1, T2, fat suppression, and diffusion-weighted imaging (DWI) — allows confident classification of virtually all ovarian cystic lesions. Fat signal on T1 and fat-suppressed sequences identifies a dermoid cyst. The T1-bright, T2-shading pattern identifies an endometrioma. The T2-hyperintense signal loss on fat suppression differentiates a hemorrhagic functional cyst (loses T1 signal) from an endometrioma (retains T1 brightness). Thick irregular walls, enhancing solid nodules, papillary projections, and restricted diffusion on DWI raise concern for ovarian malignancy. The O-RADS MRI scoring system (Ovarian-Adnexal Reporting and Data System) provides standardized risk stratification that guides management decisions from observation to surgery — a validated framework analogous to BI-RADS for breast lesions. MRI-guided management avoids unnecessary surgery for the overwhelming majority of ovarian cysts that are benign while reliably identifying those that require intervention.
Classification
Ovarian cysts are categorized by their origin and composition, each with a characteristic imaging appearance and clinical course.
- Functional cysts (follicular and corpus luteum): Arise from normal ovulatory physiology. Simple, thin-walled, resolve within 1–2 cycles. No malignant potential. Require no intervention in asymptomatic premenopausal women.
- Hemorrhagic cysts: Functional cysts with internal bleeding producing the characteristic fishnet/lace-like ultrasound pattern and T1-bright MRI signal. Resolve spontaneously. Must be distinguished from endometriomas on MRI.
- Endometriomas: Blood-filled cysts from ovarian endometriosis. Persist and enlarge rather than resolve. Managed with hormonal suppression or surgical cystectomy. See Endometrioma.
- Dermoid cysts (mature cystic teratomas): Benign germ cell neoplasms containing fat, hair, and other mature tissues. Identified by fat signal on MRI. Require surgical removal due to risk of torsion with increasing size. See Dermoid / Mature Cystic Teratoma.
- Cystadenomas (serous and mucinous): Benign epithelial ovarian neoplasms that can grow very large. Serous cystadenomas are simple or septated; mucinous cystadenomas are multiloculated with variable internal signal. Require surgical removal. See Ovarian Cystadenoma.
- Complex or suspicious cysts: Any cyst with solid enhancing components, irregular thick walls, papillary projections, or ascites. Requires urgent evaluation to exclude ovarian cancer. See Ovarian Cancer.
Treatments
Treatment is determined by cyst type, size, morphologic features on imaging, symptoms, patient age, and menopausal status. The single most important management principle is accurate characterization — getting the cyst type right through imaging determines whether safe observation, hormonal management, or surgery is appropriate.
Observation: Simple cysts under 5 cm in premenopausal women require no follow-up — they are almost certainly functional and will resolve. Simple cysts 5–10 cm warrant a single follow-up ultrasound in 8–12 weeks to confirm resolution. Most cysts with benign imaging features (including typical hemorrhagic cysts and endometriomas being conservatively managed) are monitored with serial imaging rather than immediate surgery. Ovarian cyst follow-up in postmenopausal women should be more structured — even simple cysts warrant 1–2-year surveillance given the absence of functional cyst physiology after menopause.
Hormonal therapy.
Combined oral contraceptives do not shrink existing functional cysts but suppress ovulation and prevent new functional cysts from forming — useful for women with recurrent symptomatic functional cysts. Hormonal suppression with COCs or progestins also slows endometrioma growth and reduces pain. These measures do not address dermoids, cystadenomas, or other neoplastic cysts, which continue to grow regardless of hormonal status.
Surgery.
Surgical evaluation is indicated for cysts with complex or suspicious morphology on MRI, persistent or enlarging cysts on serial follow-up, large cysts (typically over 8–10 cm) at high risk for torsion, severe pain, suspected ovarian torsion (emergency), or significant hemoperitoneum from rupture. The surgical goal is always ovarian conservation when possible — laparoscopic cystectomy removes the cyst while preserving the surrounding ovarian cortex and follicular reserve. Oophorectomy is reserved for situations where the ovary cannot be preserved or when malignancy is confirmed or strongly suspected, in which case referral to a gynecologic oncologist is appropriate for complete surgical staging.
Postmenopausal considerations.
Functional cysts do not form after menopause, so any new ovarian cyst in a postmenopausal woman warrants a more thorough evaluation pathway. Simple unilocular cysts under 1 cm are almost certainly benign and can be observed annually. Larger or morphologically complex cysts in postmenopausal women require CA-125 measurement and MRI characterization before a management decision is made — and a lower threshold for surgical referral is appropriate given the higher baseline risk of ovarian malignancy in this age group.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Pelvis MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.